A DOUBLE BLIND, RANDOMIZED, PLACEBO CONTROLLED, MULTICENTER STUDY TO EVALUATE SAFETY, TOLERABILITY, AND EFFICACY ON LDL-C OF EVOLOCUMAB (AMG 145) IN SUBJECTS WITH HIV AND WITH HYPERLIPIDEMIA AND/OR MIXED DYSLIPIDEMIN
- Registry ID
- 20130286
- Source registry
- HEALTH_CANADA
- Status
- Ongoing
- Study type
- INTERVENTIONAL
- Sponsor
- AMGEN CANADA INC
- Start date
- 2017-06-05
- Last update
- 2016-06-01
Conditions
- HUMAN IMMUNODEFICIENCY VIRUS (HIV)
- MIXED DYSLIPIDEMIA
- HYPERLIPIDEMIA
Related clinical trials
- A PHASE 3, RANDOMIZED, MULTICENTER, PARALLEL-GROUP, NON-INFERIORITY, OPEN-LABEL STUDY EVALUATING THE EFFICACY, SAFETY, AND TOLERABILITY OF CABOTEGRAVIR ULTRA LONG-ACTING PLUS RILPIVIRINE ULTRA LONG-ACTING OR CABOTEGRAVIR LONG-ACTING PLUS RILPIVIRINE LONG-ACTING IN ADULTS AND ADOLESCENTS WITH HIV WHO ARE VIROLOGICALLY SUPPRESSED ON ART
- PHASE 1/2A, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE AND MULTIPLE DOSE-ESCALATING STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PHARMACODYNAMIC EFFECTS OF ARO-DIMERPA IN ADULT SUBJECTS WITH MIXED HYPERLIPIDEMIA
- A PHASE 2 RANDOMIZED, ACTIVE-CONTROLLED STUDY EVALUATING THE SAFETY AND EFFICACY OF AN INJECTABLE REGIMEN OF GS-3242 IN COMBINATION WITH LENACAPAVIR VERSUS BIKTARVY (BICTEGRAVIR/EMTRICITABINE/TENOFOVIR ALAFENAMIDE) IN VIROLOGICALLY SUPPRESSED PEOPLE WITH HIV-1
- A PHASE 2B RANDOMIZED, OPEN-LABEL ACTIVE CONTROLLED STUDY EVALUATING THE SAFETY AND EFFICACY OF ORAL VH4524184 COADMINISTERED WITH EMTRICITABINE AND TENOFOVIR ALAFENAMIDE IN TREATMENT NAÏVE VIREMIC PERSONS WITH HIV-1 (INNOVATE STUDY)
- A PHASE 2/3, RANDOMIZED, ACTIVE-CONTROLLED, OPEN-LABEL (PHASE 2) AND DOUBLE-BLIND (PHASE 3) STUDY TO EVALUATE THE ANTIRETROVIRAL ACTIVITY, SAFETY, AND TOLERABILITY OF ISLATRAVIR (ISL) AND ULONIVIRINE (ULO) ONCE WEEKLY COMPARED WITH BICTEGRAVIR/EMTRICITABINE/TENOFOVIR ALAFENAMIDE (BIC/FTC/TAF) ONCE DAILY IN TREATMENT-NAÏVE ADULT PARTICIPANTS LIVING WITH HIV-1.
- A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ENLICITIDE DECANOATE COADMINISTERED WITH ROSUVASTATIN IN ADULTS WITH HYPERLIPIDEMIA
View on source registry